logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 18 of 18 Items
Showing 1 - 18 of 18 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan

Molina-de la Fuente I, Sagrado Benito MJ, Lasry E, Ousley J, García L,  et al.
2023-11-10 • Malaria Journal
2023-11-10 • Malaria Journal
BACKGROUND
Seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ), is a community-based malaria preventive strategy commonly used in the Sahe...
Journal Article
|
Research

AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel arm, phase 3 trial

Burza S, Mahajan R, Kazmi S, Alexander N, Kumar D,  et al.
2022-10-15 • Clinical Infectious Diseases
2022-10-15 • Clinical Infectious Diseases
BACKGROUND
Visceral leishmaniasis (VL) in patients living with Human-Immunodeficiency-Virus (HIV) present an increasingly important patient cohort in areas where both infections are ...
Conference Material
|
Abstract

Prevalence of asymptomatic Leishmania infection in HIV-positive people and progression to symptomatic visceral leishmaniasis in Bihar, India.

Mahajan R, Owen SI, Kumar S, Kazmi S, Das P,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
People co-infected with visceral leishmaniasis and HIV (VL-HIV) typically present with advanced HIV disease and in poor clinical condition. The reasons for this are comp...
Journal Article
|
Research

Malaria vector control tools in emergency settings: What do experts think? Results from a DELPHI survey

Boete C, Burza S, Lasry E, Moriana S, Robertson W
2021-12-20 • Conflict and Health
2021-12-20 • Conflict and Health
BACKGROUND
The use and implementation of novel tools for malaria control such as long lasting impregnated bednets (LLINs) and Indoor Residual Spraying (IRS) over the last decade has ...
Conference Material
|
Slide Presentation

Prevalence of asymptomatic Leishmania infection in people living with HIV (PLHIV) and progression to symptomatic visceral leishmaniasis in Bihar, India

Mahajan R, Owen SI, Kumar S, Kazmi S, Das P,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
Conference Material
|
Poster

Drivers of antibiotic prescription and use in three MSF projects in Africa

Eibs T, Koscalova A, Jimenez C, Lasry E, Kohler G,  et al.
2019-04-30 • MSF Scientific Days International 2019: Research
2019-04-30 • MSF Scientific Days International 2019: Research
Journal Article
|
Research

The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data

Bretscher MT, Dahal P, Griffin J, Stepniewska K, Bassat Q,  et al.
2020-02-25 • BMC Medicine
2020-02-25 • BMC Medicine
BACKGROUND
The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquin...
Journal Article
|
Research

Seasonal malaria chemoprevention with sulphadoxine-pyrimethamine and amodiaquine selects pfdhfr-dhps quintuple mutant genotype in Mali

Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A,  et al.
2016-09-23 • PLOS One
2016-09-23 • PLOS One
BACKGROUND
Seasonal malaria chemoprevention (SMC) with sulphadoxine-pyrimethamine (SP) plus amodiaquine (AQ) is being scaled up in Sahelian countries of West Africa. However, the pot...
Protocol
|
Research Protocol

Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational study

Chandna A, Aderie EM, Ahmad R, Arguni E, Ashley EA,  et al.
2021-01-25 • BMJ Open
2021-01-25 • BMJ Open
INTRODUCTION
In rural and difficult-to-access settings, early and accurate recognition of febrile children at risk of progressing to serious illness could contribute to improved pati...
Protocol
|
Research Protocol

A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study

Denoeud-Ndam L, Dicko A, Baudin E, Guindo O, Grandesso F,  et al.
2015-06-12 • BMC Infectious Diseases
2015-06-12 • BMC Infectious Diseases
Malnutrition and malaria frequently coexist in sub-Saharan African countries. Studies on efficacy of antimalarial treatments usually follow the WHO standardized protocol in which severel...
Journal Article
|
Research

Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola outbreak in Monrovia, Liberia, 2014

Kuehne A, Tiffany A, Lasry E, Janssens M, Besse C,  et al.
2016-08-31 • PLOS One
2016-08-31 • PLOS One
BACKGROUND
In October 2014, during the Ebola outbreak in Liberia healthcare services were limited while malaria transmission continued. Médecins Sans Frontières (MSF) implemented a m...
Journal Article
|
Research

Two-year scale-up of seasonal malaria chemoprevention reduced malaria morbidity among children in the health district of Koutiala, Mali

Maiga H, Gaudart J, Sagara I, Diarra M, Bamadio A,  et al.
2020-09-11 • International Journal of Environmental Research and Public Health
2020-09-11 • International Journal of Environmental Research and Public Health
BACKGROUND
Previous controlled studies demonstrated seasonal malaria chemoprevention (SMC) reduces malaria morbidity by >80% in children aged 3-59 months. Here, we assessed malaria m...
Journal Article
|
Research

Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned

Coldiron ME, Lasry E, Bouhenia M, Das D, Okui P,  et al.
2017-05-23 • Malaria Journal
2017-05-23 • Malaria Journal
Northern Uganda hosts a large population of refugees from South Sudan, and malaria is one of the major health problems in the area. In 2015, intermittent preventive treatment for malaria...
Journal Article
|
Commentary

Needs and challenges in modelling malaria for emergency contexts

Boëte C, Guardiola M, Lasry E, Burza S, Moriana S,  et al.
2020-09-01 • Trends in Parasitology
2020-09-01 • Trends in Parasitology
While modelling is an essential component for an understanding of the epidemiology of malaria, and for designing better control measures, it rarely considers the particular contexts enco...
Journal Article
|
Commentary

Out of (West) Africa-Who Lost in the End?

Olliaro PL, Lasry E, Tiffany A
2014-12-15 • American Journal of Tropical Medicine and Hygiene
2014-12-15 • American Journal of Tropical Medicine and Hygiene
On October 29, 2014, 4 days before the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) to be held in New Orleans, LA, meeting registrants received an e-ma...
Journal Article
|
Research

Qualitative study of antibiotic prescription patterns and associated drivers in Sudan, Guinea-Bissau, Central African Republic and Democratic Republic of Congo

Eibs T, Koscalova A, Nair MM, Grohma P, Kohler G,  et al.
2020-09-24 • BMJ Open
2020-09-24 • BMJ Open
OBJECTIVES
The objective of this study was to address the knowledge gap regarding antibiotic use in Medecins Sans Frontiéres (MSF) projects located in Africa by exploring antibiotic ...
Journal Article
|
Commentary

Malaria in pregnancy: a call for a safe, efficient, and patient-centred approach to first-trimester treatment

Rao B, Jensen TO, Jimenez BC, Robays J, Lasry E,  et al.
2018-06-06 • Lancet Global Health
2018-06-06 • Lancet Global Health
Journal Article
|
Research

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa

Taylor WRJ, Naw HK, Maitland K, Williams TN, Kapulu M,  et al.
2018-01-18 • BMC Medicine
2018-01-18 • BMC Medicine
In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), wi...